• James Garcia and Kelsey Masatoshi Kohagura James Garcia and Kelsey Masatoshi Kohagura Synedgen will accelerate the development and manufacturing component of its lead antimicrobial compounds with the addition of two new employees at its local pharmaceutical manufacturing facility. James
• James Garcia and Kelsey Masatoshi Kohagura
James Garcia and Kelsey Masatoshi Kohagura
Synedgen will accelerate the development and manufacturing component of its lead antimicrobial compounds with the addition of two new employees at its local pharmaceutical manufacturing facility.
James Garcia (Kapolei, Hawai‘i) has been appointed manufacturing associate for Synedgen. Garcia will work directly with Hawai‘i site manager Pedro Garcia and other staff to develop and implement the manufacturing systems and controls necessary to make the molecules that will be tested in FDA-regulated human clinical trials. James Garcia has more than four years manufacturing experience working in cGMP FDA-regulated laboratories synthesizing and purifying biopharmaceuticals in California.
Following graduation from Radford High School in Honolulu, James Garcia received a bachelor of science with emphasis in molecular biology from the University of California, Davis.
Kelsey Masatoshi Kohagura (Mililani, Hawai‘i) has also joined the Synedgen team as quality control associate. Kohagura, who earned his associate of arts and science in veterinary technology from San Juan College and bachelor of science in immunology from Idaho State University, will assist Synedgen in manufacturing and controls and extend Synedgen’s lead products with applications in agriculture and animal care.
Kohagura is a graduate of Mililani High School and returns to Hawai‘i following the completion of his education on the mainland. In addition to his analytical skills, he brings a unique relationship to the veterinary needs on the islands that may be met by some of the new Synedgen products.
The company is scheduled to begin human clinical testing in the fourth quarter of 2010.
